RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | -44.4% | 10,417 | +3.1% | 0.00% | – |
| Q2 2022 | $9,000 | -83.9% | 10,107 | -0.7% | 0.00% | – |
| Q1 2022 | $56,000 | -46.2% | 10,177 | -5.3% | 0.00% | – |
| Q4 2021 | $104,000 | -63.9% | 10,749 | -33.4% | 0.00% | – |
| Q3 2021 | $288,000 | -37.0% | 16,130 | -13.9% | 0.00% | – |
| Q2 2021 | $457,000 | +464.2% | 18,741 | +15.4% | 0.00% | – |
| Q3 2020 | $81,000 | -20.6% | 16,236 | -4.7% | 0.00% | – |
| Q2 2020 | $102,000 | +96.2% | 17,040 | +46.6% | 0.00% | – |
| Q1 2020 | $52,000 | -52.7% | 11,627 | 0.0% | 0.00% | – |
| Q4 2019 | $110,000 | +19.6% | 11,627 | -1.2% | 0.00% | – |
| Q3 2019 | $92,000 | -51.8% | 11,764 | -3.1% | 0.00% | – |
| Q2 2019 | $191,000 | – | 12,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |